Delivery of Phosphorescent Anticancer Iridium(III) Complexes by Polydopamine Nanoparticles for Targeted Combined Photothermal‐Chemotherapy and Thermal/Photoacoustic/Lifetime Imaging. Issue 10 (15th August 2018)
- Record Type:
- Journal Article
- Title:
- Delivery of Phosphorescent Anticancer Iridium(III) Complexes by Polydopamine Nanoparticles for Targeted Combined Photothermal‐Chemotherapy and Thermal/Photoacoustic/Lifetime Imaging. Issue 10 (15th August 2018)
- Main Title:
- Delivery of Phosphorescent Anticancer Iridium(III) Complexes by Polydopamine Nanoparticles for Targeted Combined Photothermal‐Chemotherapy and Thermal/Photoacoustic/Lifetime Imaging
- Authors:
- Zhang, Dong‐Yang
Zheng, Yue
Zhang, Hang
Sun, Jing‐Hua
Tan, Cai‐Ping
He, Liang
Zhang, Wei
Ji, Liang‐Nian
Mao, Zong‐Wan - Abstract:
- Abstract: Recently, phosphorescent iridium complexes have demonstrated great potential as anticancer and imaging agents. Dopamine is a melanin‐like mimic of mussel adhesive protein that can self‐polymerize to form polydopamine (PDA) nanoparticles that demonstrate favorable biocompatibility, near‐infrared absorption, and photothermal effects. Herein, PDA nanoparticles are functionalized with β‐cyclodextrin (CD) substitutions, which are further assembled with adamantane‐modified arginine‐glycine‐aspartic acid (Ad‐RGD) tripeptides to target integrin‐rich tumor cells. The thus formed PDA‐CD‐RGD nanoparticles can deliver a phosphorescent iridium(III) complexes LysoIr ([Ir(ppy)2 (l )]PF6, ppy = 2‐phenylpyridine, L = (1‐(2‐quinolinyl)‐β‐carboline) to form a theranostic platform LysoIr@PDA‐CD‐RGD. It is demonstrated that LysoIr@PDA‐CD‐RGD can be applied for targeted combined cancer photothermal‐chemotherapy and thermal/photoacoustic/two‐photon phosphorescence lifetime imaging under both in vitro and in vivo conditions. This work provides a useful strategy to construct multifunctional nanocomposites for the optimization of metal‐based anticancer agents for further biomedical applications. Abstract : β‐cyclodextrin‐functionalized polydopamine nanoparticles are loaded with an anticancer phosphorescent iridium(III) complex to form a multifunctional nanohybrid. The nanohybrid can further assemble with adamantane‐modified arginine‐glycine‐aspartic tripeptides targeting integrin‐richAbstract: Recently, phosphorescent iridium complexes have demonstrated great potential as anticancer and imaging agents. Dopamine is a melanin‐like mimic of mussel adhesive protein that can self‐polymerize to form polydopamine (PDA) nanoparticles that demonstrate favorable biocompatibility, near‐infrared absorption, and photothermal effects. Herein, PDA nanoparticles are functionalized with β‐cyclodextrin (CD) substitutions, which are further assembled with adamantane‐modified arginine‐glycine‐aspartic acid (Ad‐RGD) tripeptides to target integrin‐rich tumor cells. The thus formed PDA‐CD‐RGD nanoparticles can deliver a phosphorescent iridium(III) complexes LysoIr ([Ir(ppy)2 (l )]PF6, ppy = 2‐phenylpyridine, L = (1‐(2‐quinolinyl)‐β‐carboline) to form a theranostic platform LysoIr@PDA‐CD‐RGD. It is demonstrated that LysoIr@PDA‐CD‐RGD can be applied for targeted combined cancer photothermal‐chemotherapy and thermal/photoacoustic/two‐photon phosphorescence lifetime imaging under both in vitro and in vivo conditions. This work provides a useful strategy to construct multifunctional nanocomposites for the optimization of metal‐based anticancer agents for further biomedical applications. Abstract : β‐cyclodextrin‐functionalized polydopamine nanoparticles are loaded with an anticancer phosphorescent iridium(III) complex to form a multifunctional nanohybrid. The nanohybrid can further assemble with adamantane‐modified arginine‐glycine‐aspartic tripeptides targeting integrin‐rich tumors for highly effective combined photothermal‐chemotherapy and thermal/photoacoustic/two‐photon phosphorescence lifetime imaging. … (more)
- Is Part Of:
- Advanced science. Volume 5:Issue 10(2018)
- Journal:
- Advanced science
- Issue:
- Volume 5:Issue 10(2018)
- Issue Display:
- Volume 5, Issue 10 (2018)
- Year:
- 2018
- Volume:
- 5
- Issue:
- 10
- Issue Sort Value:
- 2018-0005-0010-0000
- Page Start:
- n/a
- Page End:
- n/a
- Publication Date:
- 2018-08-15
- Subjects:
- combined therapy -- iridium complexes -- polydopamine -- thermal/photoacoustic/lifetime imaging
Science -- Periodicals
505 - Journal URLs:
- http://onlinelibrary.wiley.com/journal/10.1002/(ISSN)2198-3844 ↗
http://onlinelibrary.wiley.com/ ↗ - DOI:
- 10.1002/advs.201800581 ↗
- Languages:
- English
- ISSNs:
- 2198-3844
- Deposit Type:
- Legaldeposit
- View Content:
- Available online (eLD content is only available in our Reading Rooms) ↗
- Physical Locations:
- British Library DSC - BLDSS-3PM
British Library HMNTS - ELD Digital store - Ingest File:
- 8012.xml